NCT06833853View on ClinicalTrials.gov

A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients

Not yet recruitingOBSERVATIONAL
Enrollment

187

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

October 1, 2027

Study Completion Date

March 1, 2029

Conditions
Metastatic Breast Cancer (MBC)
Trial Locations (1)

15213

UPMC Magee Womens Hospital, Pittsburgh

Sponsors
All Listed Sponsors
lead

Menarini Silicon Biosystems, INC

INDUSTRY